Hypertensive disorders of pregnancy (HDP), defined as a sex-specific cardiovascular disease, is one of the leading causes of maternal and fetal morbidity and mortality globally and a critical threat to maternal and infant health.  Preeclampsia is a pregnancy-related hypertensive disorder occurring usually after 20 weeks of gestation and if left untreated, it progresses to<unk> . Preeclampsia and<unk>  are not distinct disorders but the manifestation of the spectrum of clinical symptoms of the same condition. Although preeclampsia prevails to be a significant public health threat in both developed and developing nations bringing maternal and perinatal morbidity and mortality worldwide, the impact of the disease is witnessed to be harsher in the developing countries  ,where, unlike other more prevalent causes of maternal mortality (such as haemorrhage and sepsis), medical interventions may be ineffective due to late presentation of cases. The problem is confounded by the continued ambivalence of the aetiology and the unpredictable behavior of the disease . According to WHO, the incidence of preeclampsia is seven times higher in developing countries (2.8% of live births) than in developed countries (0.4%). In developing countries the prevalence of preeclampsia, the precursor of<unk> , ranges from 1.8% to 16.7% and from 1990 to 2019, the incidence, prevalence, death and YLDs were highest in populations aged 25–29 years.
Eclampsia epidemiology and demographics
Thrombophilia epidemiology and demographics
High density lipoprotein epidemiology and demographics
Low density lipoprotein epidemiology and demographics
Subarachnoid hemorrhage epidemiology and demographics
Sudden cardiac death laboratory findings
Metabolic syndrome epidemiology and demographics
Polycythemia epidemiology and demographics